Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gritstone bio
AddedFeb 19, 2024
UpdatedJul 17, 2026
Gritstone bio

Gritstone bio

Public

Gritstone Bio, Inc., a US-based biotech firm, specializes in producing and distributing cancer care drugs.

HQ
Emeryville, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Gritstone bio, Inc., founded in August 2015 and based in Emeryville, California, is a clinical-stage American biotechnology company. Its core mission is to develop groundbreaking immunotherapies for cancers and infectious diseases by leveraging the natural power of a patient’s immune system. The company focuses on generating therapeutic immune responses to recognize and destroy tumors or virally infected cells. Gritstone bio offers cancer care drugs and is also developing vaccines, including a second-generation SARS-CoV-2 vaccine.

Notable affiliated individuals include its founders and key scientific advisors, who are leaders in oncology and immunotherapy. In September 2021, Gritstone bio raised $55 million from the sale of 5,000,000 shares, highlighting strong investor confidence. The company has initiated several clinical trials, including a Phase 1 trial for its self-amplifying mRNA SARS-CoV-2 vaccine. Gritstone bio's innovative approach has the potential to significantly impact cancer treatment and infectious disease management, positioning it as a pioneering force in the biotech industry.

Gritstone bio - Similar Companies

Grit Bio logo

Grit Bio

GRAIL logo

GRAIL

grail.com

INmune Bio logo

INmune Bio

inmunebio.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Nantkwest logo

Nantkwest

Gitr logo

Gitr

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Cancervax logo

Cancervax

cancervax.com

ImmunityBio logo

ImmunityBio

immunitybio.com

BeOne Medicines logo

BeOne Medicines

beigene.com

OncoResponse logo

OncoResponse

Grid Therapeutics logo

Grid Therapeutics

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

NextCure logo

NextCure

nextcure.com

Gritstone bio - Quick Facts

Who are Gritstone bio's competitors?

Companies similar to Gritstone bio include Grit Bio, GRAIL, INmune Bio and Iovance Biotherapeutics.

When was Gritstone bio founded?

Gritstone bio was founded in 2015.

Where is Gritstone bio's headquarters located?

Gritstone bio's headquarters is located in Emeryville, CA, US.

When was Gritstone bio's last funding round?

Gritstone bio's most recent funding round was for $80M (USD) in July 2022.

How much has Gritstone bio raised to-date?

As of Jul 22, 2022, Gritstone bio has raised a total of $571.6M (USD).

How many employees does Gritstone bio have?

Gritstone bio has 233 employees as of Feb 6, 2024.

Gritstone bio - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Drugs
  • Vaccines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research